26.11.2019 - US Merck & Co. has agreed to buy Calporta Therapeutics for up to $576 million, including an upfront sum and contingent milestone payments. Calporta was launched in early 2015 by...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)